Chronos® Max
Chronos® Max, patented UV-C technology with light speed efficiency

- Reproducible automated cycle in about 4 minutes*
- Reduce the risk of human error
- Immediate availability of probes after the HLD cycle: no rinsing, no wiping, no waiting time

- Integral disinfection: active part, cable and connector
- Inactivation of HIV**
- Inactivation of HPV**1,2 (clinical tests) responsible, among others, for oropharyngeal cancer 3-5
- Effective against staphylococci (S. aureus) and enterococci, particularly those responsible for infectious endocarditis

Complete traceability of the HLD cycle:
- Operator’s identification
- Medical Device detection inside the chamber
- Automatic label printing
- Germitrac: Embedded software for digital access

- Validation of the latest TEE probes and ENT endoscopes without operating channel
- 2-in-1 system for ENT and Cardiology

- Improved recyclability with 32% fewer components†
- Chemical-free solution with low energy consumption
Frequently asked questions
Chronos® Max is a class IIb device, CE marked according to MDR 2017/745.
Based on the exposure test protocol, co-validated by Germitec and the leading ultrasound probe manufacturers, a dedicated team manages long-term compatibility campaigns with accelerated weathering tests which can be performed 24/7 over several months.
To ensure an optimal High-Level Disinfection without any blind spots nor shadow areas and an optimal traceability, Chronos® Max can only disinfect one medical device at a time.
The Chronos® Max can therefore be installed in an examination room, close to the patient. During the High-Level Disinfection cycle, the sound volume is between 25 dB and 46 dB, no more than the noise of a dishwasher in operation.
1. Meyers C, et al. (2017) UVC Radiation as an Effective Disinfectant Method to Inactivate Human Papillomavirus PLoS ONE 12 (10) : e0187377
2. Pichon M, et al. (2019) Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV Using UV-C Decontamination System (Décontamination des sondes intravaginales infectées par le papillomavirus humain (HPV) à l'aide d'un système de décontamination UV-C). J. Clin. Med, 8, 1776;doi:10.3390/jcm8111776
3. Les traitements des cancers des voies aérodigestives supérieures, collection Guides patients Cancer info, INCa, décembre 2018.
4. Cancers des voies aérodigestives supérieures. Outils pour la pratique. Du diagnostic au suivi. Février 2018.
5. Barsouk A et al. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Med Sci (Basel). 2023;11:42.7.
* Internal data: cycle duration subjects to reaching the predefined UV-C dose validating the HLD cycle
** HPV : Human papillomavirus // ** VIH : Human immunodeficiency virus
*** EN 14885:2022 (Healthcare technology – Sterilization and disinfection) Chemical disinfectants and antiseptics - Application of European Standards for chemical disinfectants and antiseptics
† Internal data: comparative calculations of spare parts between Antigermix® (AE1-V1) and Chronos® Max (AE1-V2)